Acute intestinal intussusception among children under five years of age admitted in an Ouagadougou hospital, Burkina Faso, 2008-2013: epidemiological, clinical and therapeutic aspects.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2021
Historique:
received: 30 07 2020
accepted: 15 10 2020
entrez: 22 9 2021
pubmed: 23 9 2021
medline: 9 10 2021
Statut: epublish

Résumé

acute intestinal intussusception is a life-threatening surgical condition. In some settings, rotavirus vaccines have been associated with a low-level increased risk of intussusception. We describe the epidemiology, clinical manifestations and management of intussusception in a tertiary referral hospital in Burkina Faso prior to the introduction of rotavirus vaccine in October 2013. we retrospectively reviewed medical records of all children under 5 years of age treated at the Charles de Gaulle Pediatric Hospital for intussusception meeting the Brighton level 1 diagnostic criteria, from October 31st, 2008 to October 30th, 2013. We report the incidence of intussusception as well as descriptive characteristics of these cases. a total of 107 Brighton level 1 intussusception cases were identified, representing a hospital incidence of 21.4 cases / year. There were 69 males and 38 females (sex ratio of 1.8), with a median age of 8 months (range 2 months to 4 years). Sixty-two percent of intussusception cases occurred among infants (n = 67 cases). The average time from symptom onset to seeking medical consultation was 3.8 days +/- 2.7 (range 0 to 14 days). Treatment was mainly surgical (105 patients, 98.1%) with 35 patients (32.7%) undergoing intestinal resection. Thirty-seven patients (35.5%) experienced post-operative complications. The mortality rate was 9.3%. Intestinal resection was a risk factor for death from intussusception. in this review of intussusception hospitalizations prior to rotavirus vaccine introduction in Burkina Faso, delays in seeking care were common and were associated with mortality.

Identifiants

pubmed: 34548897
doi: 10.11604/pamj.supp.2021.39.1.25270
pii: PAMJ-SUPP-39-1-5
pmc: PMC8437429
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

©Tapsoba Wendlamita Toussaint et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

MMWR Morb Mortal Wkly Rep. 1999 Nov 5;48(43):1007
pubmed: 10577495
J Radiol. 2001 Nov;82(11):1651-4
pubmed: 11894553
Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S99-S103
pubmed: 24343624
Vaccine. 2011 Apr 5;29(16):3061-6
pubmed: 21316503
J Pediatr. 2006 Oct;149(4):452-60
pubmed: 17011313
Wkly Epidemiol Rec. 2009 Dec 18;84(50):533-40
pubmed: 20034143
N Engl J Med. 2018 Apr 19;378(16):1521-1528
pubmed: 29669224
Pediatrics. 2002 Dec;110(6):e67
pubmed: 12456934
Ann Afr Med. 2010 Jan-Mar;9(1):27-30
pubmed: 20418646
N Engl J Med. 2011 Jun 16;364(24):2283-92
pubmed: 21675888
Ghana Med J. 2011 Sep;45(3):128-31
pubmed: 22282581

Auteurs

Tapsoba Wendlamita Toussaint (TW)

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouadougou, Burkina Faso.

Albert Wandaogo (A)

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouadougou, Burkina Faso.

Idrissa Clétus Yaméogo W (IC)

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouadougou, Burkina Faso.

Isso Ouédraogo (I)

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouadougou, Burkina Faso.

Somkièta Modeste Francis Ouédraogo (SMF)

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouadougou, Burkina Faso.

Olivier Zampou (O)

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouadougou, Burkina Faso.

Bernadette Béré (B)

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouadougou, Burkina Faso.

Negar Aliabadi (N)

Centers for Disease Control and Prevention, Atlanta, United States.

Eyal Leshem (E)

Centers for Disease Control and Prevention, Atlanta, United States.

Moumouni Nikièma (M)

Ministry of Health, Burkina Faso.

Ma Ouattara (M)

World Health Organization, Burkina Faso.

Jason M Mwenda (JM)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Isidore Bonkoungou (I)

National Public Health Laboratory, Burkina Faso.

Emile Bandré (E)

Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouadougou, Burkina Faso.

Umesh D Parashar (UD)

Centers for Disease Control and Prevention, Atlanta, United States.

Jacqueline E Tate (JE)

Centers for Disease Control and Prevention, Atlanta, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH